T-cell receptor CDR3 size distribution analysis to evaluate specific T-cell response to cancer vaccines.
about
DNA demethylating agent decitabine broadens the peripheral T cell receptor repertoire.Comparative assessment of TCRBV diversity in T lymphocytes present in blood, metastatic lesions, and DTH sites of two melanoma patients vaccinated with an IL-7 gene-modified autologous tumor cell vaccine.Reconstitution of the T-cell repertoire following treatment with alemtuzumab (anti-CD52 monoclonal antibody) in patients with B-cell chronic lymphocytic leukaemia.CD4 positive peripheral T cells from patients with systemic lupus erythematosus (SLE) are clonally expanded.The expanded double negative T cell populations of a patient with ALPS are not clonally related to CD4+ or to CD8+ T cells
P2860
T-cell receptor CDR3 size distribution analysis to evaluate specific T-cell response to cancer vaccines.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
T-cell receptor CDR3 size dist ...... l response to cancer vaccines.
@en
T-cell receptor CDR3 size dist ...... l response to cancer vaccines.
@nl
type
label
T-cell receptor CDR3 size dist ...... l response to cancer vaccines.
@en
T-cell receptor CDR3 size dist ...... l response to cancer vaccines.
@nl
prefLabel
T-cell receptor CDR3 size dist ...... l response to cancer vaccines.
@en
T-cell receptor CDR3 size dist ...... l response to cancer vaccines.
@nl
P2093
P1476
T-cell receptor CDR3 size dist ...... l response to cancer vaccines.
@en
P2093
B Escudier
C Leboullaire
I Poullion
P304
P356
10.1002/(SICI)1097-0215(19970611)71:6<972::AID-IJC11>3.0.CO;2-8
P50
P577
1997-06-01T00:00:00Z